GlassScriptActelion Pharmaceuticals US, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$22Mgeneral payments (2019-2025)
$29Kresearch payments (2019-2025)
30,730clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Uptravi $11M associated (2023-2025)
- Opsumit $11M associated (2023-2025)
- Opsynvi $158K associated (2023-2025)
- Xarelto $209 associated (2023-2025)
- Bosentan $208 associated (2023-2025)
- Veletri $137 associated (2023-2025)
- Acclaim $96.80 associated (2023-2025)
- Invega Sustenna $76.59 associated (2023-2025)
- Ventavis $70.76 associated (2023-2025)
- Acclarent Aera $66.87 associated (2023-2025)
- Tremfya $65.16 associated (2023-2025)
- Amo Phaco Needle $31.51 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Hunter Champion | Columbus, GA | Cardiovascular Disease | $637,637.64 |
| John Mcconnell | Louisville, KY | Pulmonary Disease | $575,067.00 |
| John Ryan | Salt Lake City, UT | Cardiovascular Disease | $522,656.63 |
| Ashish Gupta | Phoenix, AZ | Cardiovascular Disease | $475,241.81 |
| Omar Minai | Hopewell, VA | Pulmonary Disease | $444,411.69 |
| Ronald Zolty | Omaha, NE | Cardiovascular Disease | $409,300.90 |
| Hyong Kim | La Jolla, CA | Internal Medicine | $368,030.08 |
| Paul Forfia | Philadelphia, PA | Cardiovascular Disease | $362,825.67 |
| Anjali Vaidya | Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | $341,018.19 |
| Richard Channick | Boston, MA | Critical Care Medicine (Internal Medicine) | $320,019.67 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.